[Federal Register Volume 88, Number 102 (Friday, May 26, 2023)]
[Notices]
[Pages 34154-34155]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11303]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) 
announces a Special Emphasis Panel (SEP) meeting on ``Dissemination and 
Implementation of Equity-Focused Evidence-Based Interventions in 
Healthcare Delivery Systems (R18)''. This SEP meeting will be closed to 
the public.

DATES: July 11-12, 2023.

ADDRESSES: Agency for Healthcare Research and Quality, (Video Assisted 
Review), 5600 Fishers Lane, Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 
Fishers Lane, Rockville, Maryland 20857, Telephone: (301) 427-1557.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
AHRQ, and agree to be available, to conduct on an as needed basis, 
scientific reviews of applications for AHRQ support. Individual members 
of the Panel do not attend regularly scheduled meetings and do not 
serve for fixed terms or a long period of time. Rather, they are asked 
to participate in particular review meetings which require their type 
of expertise.
    The SEP meeting referenced above will be closed to the public in 
accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C. 
552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for 
``Dissemination and Implementation of Equity-Focused Evidence-Based 
Interventions in Healthcare Delivery Systems (R18)'' are to be reviewed 
and discussed at this meeting. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Agenda items for this meeting are subject to change as priorities 
dictate.


[[Page 34155]]


    Dated: May 22, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-11303 Filed 5-25-23; 8:45 am]
BILLING CODE 4160-90-P